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The discovery of mutations in cancer genes has advanced our understanding of cancer. These results are dispersed across the
scientific literature and with the availability of the human genome sequence will continue to accrue. The COSMIC (Catalogue of
Somatic Mutations in Cancer) database and website have been developed to store somatic mutation data in a single location and
display the data and other information related to human cancer. To populate this resource, data has currently been extracted from
reports in the scientific literature for somatic mutations in four genes, BRAF, HRAS, KRAS2 and NRAS. At present, the database holds
information on 66634 samples and reports a total of 10647 mutations. Through the web pages, these data can be queried, displayed
as figures or tables and exported in a number of formats. COSMIC is an ongoing project that will continue to curate somatic mutation
data and release it through the website.
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Approximately one in three individuals in Europe and North
America develops one of the approximately 200 different classes of
cancer and it is the cause of death of one in five (Higginson, 1992).
All cancers arise as a result of the acquisition of a series of fixed
DNA sequence abnormalities, each of which ultimately confers
growth advantage upon the clone of cells in which it has occurred
(Vogelstein and Kinzler, 1998). These abnormalities include base
substitutions, deletions, amplifications and rearrangements. The
extent to which each of these mechanisms contributes to cancer
varies markedly between different genes, and probably also
between different cancer types. Identification of the genes that
are mutated in cancer is a central aim of cancer research. Over the
past 25 years, approximately 300 genes have been shown to be
somatically mutated in cancer (Futreal et al, 2004). This work
forms the foundation for understanding the biological abnormal-
ities within neoplastic cells, provides information on the function
of gene products and sheds light on more complex questions such
as the relationships between genes and biochemical pathways.
Current strategies for the development of new therapeutic and
preventive agents in cancer are increasingly dependent upon
modulation of these critical molecular targets.
The scientific literature is a rich source of mutation data that, in
general, is published in a piecemeal fashion. More comprehensive
data sources do exist, such as Online Mendelian Inheritance in
Man (OMIM, Wheeler et al, 2004), HGVbase (Fredman et al, 2002)
and the Human Gene Mutation Database (HGMD, Stenson et al,
2003). These databases give overviews of the genetics and biology
of many genes and associated diseases (OMIM), genome variants
and associated genotype–phenotype relationships (HGVbase) or
germline mutation data (HGMD). For somatic mutations in cancer,
there are many locus-specific web resources, such as those for p53
(Olivier et al, 2002; Be ´roud and Soussi, 2003), that cover a single
gene in depth. The value of these various databases should not be
underestimated; however, none of them offer a comprehensive
view of all previously reported somatic mutations in cancer.
Looking to the future, the volume of somatic mutation data will
continue to expand and the scientific community will be better
served if this data is provided in a coherent fashion. A public,
comprehensive, intuitive, accessible and integrated database is
required to maximise the benefit from this rich data set. The
Catalogue of Somatic Mutations in Cancer (COSMIC), (http://
www.sanger.ac.uk/cosmic) is a database that holds somatic
mutation data and associated information, and can be interrogated
through a series of web pages to provide a graphical or tabular
view of the data along with various export options. To date, the
database has been populated with data from four genes: HRAS,
KRAS2, NRAS and BRAF.
DATA CURATION
Gene selection
The genes that have been selected for curation are taken from the
list of cancer genes assembled in the Cancer Gene Census (Futreal
et al, 2004). In the first instance, data was obtained for four genes
that are known to be somatically mutated in cancer: HRAS (Reddy
et al, 1982), KRAS2 (McCoy et al, 1983), NRAS (Hall et al, 1983)
and BRAF (Davies et al, 2002).
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PubMed (Wheeler et al, 2004) is broadly searched for references
containing relevant somatic mutation data in cancer (example
search: (ras OR genes, ras) AND human AND mutation). In
the first instance, the abstract is read to identify, and select
for inclusion in the database, papers that are likely to include
somatic mutation information relating to cancer or precancerous
conditions. Primary research papers are read and informa-
tion about the samples, mutations and experimental methods
(see Table 1) is extracted and entered into the database. Reviews
are also selected if thought to be specific to a gene of interest.
In order to avoid duplication of data, this source is used to
identify the relevant primary literature and not as the source
of the mutation data. Any references containing incomplete data
(e.g. mutations reported but not fully described) or data of
insufficient quality (e.g. errors identified in the data) are not
fully curated but are added to a list of additional references
containing somatic mutation information. Simple mutations are
fed through Mutation Checker (Stajich et al, 2002) before being
imported to COSMIC, while more complex alterations are
manually annotated.
COSMIC DATABASE
The COSMIC database is implemented in an Oracle relational
database and has five sections each containing multiple tables.
Gene information
A static version of each gene is maintained in COSMIC. The
genomic structure of each gene and chromosome location is
derived from Ensembl (Birney et al, 2004) and cDNA sequence and
protein sequence from the RefSeq project (Wheeler et al, 2004).
Other information is held to provide links to web resources such as
Ensembl (Birney et al, 2004), Pfam (Bateman et al, 2004), InterPro
(Mulder et al, 2003) and OMIM (Wheeler et al, 2004).
Table 1 Data entered in COSMIC
Reference Sample
Title Gene
Authors Experimental information
Journal Sample ID
Year Mutation status
Volume Normal tissue tested
Page start and stop Site primary
PubMed ID Site subtype 1
Experimental information Site subtype 2
Gene Histology
Histology subtype 1
Mutation Histology subtype 2
Mutation ID Stage
Mutation type Grade
DNA location Source tissue
DNA change Loss of heterozygosity
DNA evidence Gender
Is somatic Age
RNA label Other mutations
RNA change Ethnicity
RNA region Geographical location
RNA location Parent tested
RNA evidence Family ID
Amino-acid label Remark
Amino-acid location Reference
Amino-acid change Environmental variables
Amino-acid evidence
Gene Gene
Sequence Name
Remark Symbol
Other names
Experimental information Chromosome
Primary detection method Chromosome band
Secondary detection method cDNA sequence accession
Confirmation method cDNA sequence version
Exons/codons screened Ensembl gene start and stop
Whole gene screened Swissprot accession
Remark OMIM accession
Section heading for the data in COSMIC are in bold.
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The details of the papers that have been curated are maintained in
the paper section and include title, journal, author lists and links to
PubMed. There are currently 1483 papers in COSMIC, 865 of these
have been curated for mutations, while 618 either have no relevant
data or incomplete data that could not accurately be extracted. By
gene 30, 249, 718 and 303 papers report BRAF, HRAS, KRAS2 and
NRAS mutations, respectively. Of the 865 papers reporting
mutations, 615 report data on only one gene, while 72, 174 and
four contain data on two, three or all four genes, respectively.
Mutation information
COSMIC can accommodate information on base substitutions,
insertions and deletions, translocations and changes in copy
number. For the four genes presently in COSMIC, there are 147
unique mutations (36 for BRAF, 27 for HRAS, 52 for KRAS2 and 32
for NRAS). In the tumours that have been analysed, there are a
total of 10647 mutations, 736 in BRAF, 477 in HRAS, 8302 in
KRAS2 and 1132 in NRAS.
Tumour classification system
The tissue site and histology data is taken from the curated papers
and entered into COSMIC (this forms the ‘paper definition’).
Tumour classification is a continually evolving field and there is no
standard nomenclature adhered to for the purposes of publication
in the various journals. Identical tissues and histologies can have
different labels depending on the origin and age of the study. To
overcome difficulties caused by these alternate nomenclatures, a
standardised system of definitions has been developed (the
‘COSMIC definitions’) through consultation with experts in the
field. This groups data from the same tissue types and histologies
and can be used to translate the ‘paper definitions’ to ‘COSMIC
definitions’. Every sample has up to eight definitions; primary
tissue, tissue subtype 1, 2 and 3, primary histology and histology
subtypes 1, 2 and 3. If there is no data for any of these definitions,
COSMIC records an entry of NS, not specified. A total of 513 tissue
definitions have been noted in the papers in COSMIC and have
been translated to 372 COSMIC tissue definitions. Likewise, a total
of 1150 histology definitions were found in the papers in COSMIC
that were translated to 425 COSMIC histology definitions. This
unified classification system is presented through the web pages to
present a normalised browsing tool.
Individual/tumour/sample data
The sample data is taken from the curated papers and linked to the
appropriate gene, paper, classification and when present a
mutation. This forms the core of the COSMIC database. An
individual can have many tumours and each tumour can have
many samples. However in the COSMIC scheme, each sample is
unique and could be considered as a single experiment. There are
66634 sample records in COSMIC (5158, 11876, 35716 and 13884
for BRAF, HRAS, KRAS2 and NRAS, respectively). These samples
are derived from 57444 tumours of which 51988 were analysed in
one gene, 2353 in two genes, 2930 in three genes and 173 in all four
genes.
COSMIC WEBSITE
A series of web pages provides query tools to interrogate COSMIC
and produces graphical (Figure 1) and tabular (Table 2) displays of
the data. Currently the output is provided at the amino-acid level
based on the protein structure of each gene.
Browse by gene
Immediate access to the data is provided through the Browse by
Gene link. This gives an instant overview of the mutation data for
one or more genes and gives links to display data for individual
tissues.
Browse by tissue
More complex queries can be constructed using the Browse by
Tissue link. The user has the option to select one or more tissues,
Figure 1 The initial output from COSMIC is a graphical view of the mutations distributed along the linear amino-acid sequence of the gene. The scale bar
incorporates a zoom function to generate a more detailed view of the protein to the point where individual amino acids are named (when there are fewer
than 31 amino acids displayed). When a Pfam or Interpro domain is present, a link is provided to these resources (adjacent to the Domain label) while links
to the papers that were curated are positioned beneath the mutations (in red) with an option of either viewing the papers that have data for a particular
location in the protein or all of the papers for the selected gene.
Table 2 Mutation Details from COSMIC
Details for BRAF
Tissue
Mutations
(% of All Samples) All Samples Mutation Data
NS 0 3 More Details
adrenal gland 0 2 More Details
autonomic ganglia 0 27 More Details
bile duct 16 (23%) 70 More Details
bladder 0 37 More Details
bone 1 (3%) 31 More Details
brain 4 (7%) 56 More Details
breast 1 (1%) 78 More Details
cervix 0 49 More Details
endometrium 0 5 More Details
eye 0 31 More Details
haematopoietic and
lymphoid tissue
4 (1%) 322 More Details
head neck 6 (4%) 152 More Details
kidney 0 12 More Details
large intestine 148 (13%) 1135 More Details
larynx 0 25 More Details
liver 1 (3%) 32 More Details
lung 15 (2%) 829 More Details
mouth 0 13 More Details
ovary 57 (20%) 282 More Details
pancreas 5 (4%) 114 More Details
pharynx 3 (6%) 51 More Details
placenta 0 1 More Details
pleura 0 3 More Details
prostate 0 43 More Details
skin 282 (61%) 460 More Details
small intestine 0 1 More Details
soft tissue 5 (2%) 211 More Details
stomach 7 (2%) 407 More Details
testis 0 7 More Details
thyroid 181 (27%) 669 More Details
The mutations from COSMIC are presented by tissue and where selected by
histology with a figure for the number of samples analysed for each tissue (All
Samples) and the number of mutations reported (Mutated). The ‘More Details’
column gives further navigation options to view data for the selected tissue, view data
for the same tissue in other genes or provide more details on the mutations for the
selected tissue.
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one tissue or histology is selected, it is possible to select one or
more tissue or histology subtypes before making a gene selection.
All of the tissues present in the COSMIC classification scheme are
available from the first page; however, subsequent pages only show
the relevant options and not the entire list of options, for example
having selected eye, the tissue subtype options are retina and uveal
tract.
Data display
After querying the database, the results are displayed as a figure
(Figure 1) and as a series of tables (Table 2) for each gene that was
selected. The figure shows the linear amino-acid sequence derived
from the gene with the mutations positioned along its length.
Further information and links are provided as appropriate to the
protein sequence. The table gives a summary of the mutations
stratified by tissue and histology. The depth of the stratification
relates to the depth of the original query. If only tissue was
selected, the data will be stratified by tissue; however, if tissue,
subtissue, histology and subhistology are selected, the data will be
broken down further. Links from this table reload the figure to
display a subset of the data and provide more details of the specific
mutations. Two other tables provide a summary of the statistics in
COSMIC for the selected gene and a summary of the mutations
shown in the figure.
Exports and downloads
Having displayed the results from a query, the data can be
formatted in simple text, Excel or HTML that can be downloaded
from the COSMIC site. The cDNA and protein sequences are
available through the Additional Info. link on the COSMIC home
page as is the Classification Scheme.
FUTURE DIRECTIONS
There is a continuing effort to enter additional somatic mutation
data in to COSMIC. In order to keep the data in COSMIC up-to-
date, we regularly monitor the literature for new reports of
mutations in the genes that exist in COSMIC. In addition, further
cancer genes will be taken from the Cancer Gene Census (Futreal
et al, 2004) and curated. The COSMIC website will be developed
further to make use of the underlying data. This will include a
DNA view of the mutations and methods to display insertions and
deletions. In addition, we will display other data that has already
been captured such as the patient sex and age for the samples and
the experimental methods used to screen for the mutations. There
are however limitations to this data as we can only collect data that
is described in the original work. Even with this caveat the data
provides a direct summary of the somatic mutation literature.
Considering the data set as a whole it will be possible to analyse, in
greater detail, the wider aspects of the biology underlying the
genetic changes that take place in cancer.
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